NCT06465381 Safety Planning and Cognitive Behavioral Therapy for Adolescent Suicide Prevention in Mozambique
| NCT ID | NCT06465381 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Washington |
| Condition | Suicide Prevention |
| Study Type | INTERVENTIONAL |
| Enrollment | 2,100 participants |
| Start Date | 2025-09-01 |
| Primary Completion | 2027-12-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 2,100 participants in total. It began in 2025-09-01 with a primary completion date of 2027-12-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This implementation research project aims to test the effectiveness and implementation outcomes of suicide safety planning along and a transdiagnostic cognitive behavioral intervention for suicide prevention on decreasing suicidal behaviors in secondary school students in Mozambique. This study will also result in hypothesized mechanisms of intervention effects, costs and cost-effectiveness.
Eligibility Criteria
Inclusion Criteria: Inclusion criteria for suicide risk screening: 1. Youth enrolled in a secondary school in Sofala Province that is located within 30 minutes of a health facility that hosts both an urgent care and mental health department. 2. Youth enrolled in 9th and/or 10th and/or 11th grade. 3. Legal guardian has provided consent to participate if under 18 or if youth is age 18 or older and has provided consent to participate. 4. Youth has assented to participation. Inclusion criteria for trial participation and allocation to study arm: 1\. Youth expresses active suicidal ideation on the Columbia Suicide Severity Rating Scale (C-SSRS). Exclusion Criteria: 1. Youth and/or guardian has not provided consent to participate, or responsible party is unable to provide informed consent. 2. Youth is not enrolled in a participating secondary school. 3. Youth declines to assent. 4. Youth is a ward of the State or any other agency, institution, or entity.
Contact & Investigator
Bradley Wagenaar, PhD, MPH
PRINCIPAL INVESTIGATOR
University of Washington
Frequently Asked Questions
Who can join the NCT06465381 clinical trial?
This trial is open to participants of all sexes, studying Suicide Prevention. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06465381 currently recruiting?
Yes, NCT06465381 is actively recruiting participants. Contact the research team at morgank2@uw.edu for enrollment information.
Where is the NCT06465381 trial being conducted?
This trial is being conducted at Beira, Mozambique, Caia, Mozambique, Cheringoma., Mozambique, Chibabava, Mozambique and 3 additional locations.
Who is sponsoring the NCT06465381 clinical trial?
NCT06465381 is sponsored by University of Washington. The principal investigator is Bradley Wagenaar, PhD, MPH at University of Washington. The trial plans to enroll 2,100 participants.